U.S. markets closed
  • S&P 500

    4,112.50
    +49.46 (+1.22%)
     
  • Dow 30

    34,021.45
    +433.79 (+1.29%)
     
  • Nasdaq

    13,124.99
    +93.31 (+0.72%)
     
  • Russell 2000

    2,170.95
    +35.81 (+1.68%)
     
  • Crude Oil

    63.79
    -2.29 (-3.47%)
     
  • Gold

    1,826.80
    +4.00 (+0.22%)
     
  • Silver

    27.18
    -0.06 (-0.23%)
     
  • EUR/USD

    1.2085
    +0.0009 (+0.07%)
     
  • 10-Yr Bond

    1.6680
    -0.0270 (-1.59%)
     
  • GBP/USD

    1.4050
    -0.0008 (-0.05%)
     
  • USD/JPY

    109.4240
    -0.2360 (-0.22%)
     
  • BTC-USD

    49,667.79
    -4,896.26 (-8.97%)
     
  • CMC Crypto 200

    1,342.60
    -45.30 (-3.26%)
     
  • FTSE 100

    6,963.33
    -41.30 (-0.59%)
     
  • Nikkei 225

    27,448.01
    -699.50 (-2.49%)
     

Wave Life Sciences (WVE) President and CEO Paul Bolno Sold $1.5 million of Shares

GuruFocus.com
·1 min read

- By insider

President and CEO of Wave Life Sciences (30-Year Financial, Insider Trades) Paul Bolno (insider trades) sold 100,000 shares of WVE on 09/15/2020 at an average price of $15 a share. The total sale was $1.5 million.


WAVE Life Sciences Ltd is a preclinical therapeutics developer in Singapore. Its pipeline of drugs is intended to cure rare genetic disorders such as Huntington, duchenne muscular dystrophy (DMD) and inflammatory bowel disease. WAVE Life Sciences Ltd has a market cap of $701.160 million; its shares were traded at around $19.09 with and P/S ratio of 52.74. GuruFocus has detected 4 severe warning signs with WAVE Life Sciences Ltd. .

CEO Recent Trades:

  • President and CEO Paul Bolno sold 100,000 shares of WVE stock on 09/15/2020 at the average price of $15. The price of the stock has increased by 27.27% since.

  • President and CEO Paul Bolno sold 25,000 shares of WVE stock on 08/25/2020 at the average price of $12. The price of the stock has increased by 59.08% since.

For the complete insider trading history of WVE, click here

.This article first appeared on GuruFocus.